Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.
Press releases published on August 7, 2025
Geotab viert 25 jaar & geeft toekomst van verbonden voertuigen vorm
AMSTERDAM and ANTWERP, Belgium, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Vandaag viert Geotab zijn 25-jarig jubileum met een terugblik op indrukwekkende wereldwijde groei, baanbrekende innovaties op het gebied van AI en een focus op klanten, partners en …
Tidewave Bio Reaches Key Regulatory Milestone with FDA INTERACT Meeting Scheduled for August 2025
LOS ANGELES, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Tidewave Bio, a biotechnology company developing a novel immune activation platform for solid tumors, today announced that the U.S. Food and Drug Administration (FDA) has accepted its request for an INTERACT …
Belite Bio Announces Registered Direct Offering of $15 Million
The offering was to a single large existing institutional shareholder SAN DIEGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc ("BLTE" or the "Company") (Nasdaq: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics …
Barinthus Bio Reports Second Quarter 2025 Financial Results and Updates on Corporate Developments
The final cohort of the single ascending dose (SAD) part of the Phase 1 AVALON trial initiated, with the SAD data readout expected early in the fourth quarter of 2025; The multiple ascending dose (MAD) part of the AVALON trial initiated; Available …
Rocket Doctor Strengthens Access to Care Across Ontario as ER Closures and Physician Shortages Rise
2024 marked the worst year on record for ER closures in Ontario, with 1 in 5 hospitals experiencing unplanned shutdowns, especially in rural areas. Ontario’s family physician workforce is aging, with 15% of patients attached to doctors nearing retirement …
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2025
PORTLAND, Maine, Aug. 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …
UroGen Pharma Expands Commercial Portfolio with Launch of ZUSDURI™ and Reports Second Quarter 2025 Financial Results
ZUSDURI™ (mitomycin) for intravesical solution now available as the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) JELMYTO® achieved net product sales of $24.2 …
Labrynth Launches the Red Tape Index to Help America Build Smarter, Faster
WASHINGTON, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Labrynth, a regulatory intelligence company dedicated to streamlining permitting approvals across government and industry, today announced the launch of the Red Tape Index. This new index provides the first …
MBX Biosciences Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
Topline results for the Phase 2 Avail™ trial of canvuparatide in hypoparathyroidism on track for Q3 2025 Imapextide (MBX 1416) Phase 2a trial initiation in patients with post-bariatric hypoglycemia anticipated in Q3 2025 MBX 4291 Phase 1 trial initiation …
Ascentage Pharma to Report 2025 Six Month Interim Results and Provide Corporate Update on August 20, 2025
ROCKVILLE, Md. and SUZHOU, China, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in …
Zscaler to Host Fourth Quarter Fiscal Year 2025 Earnings Conference Call
SAN JOSE, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, will release fourth quarter fiscal year 2025 earnings after the market closes on Tuesday, September 2, 2025. The company will host an investor …
Replimune Reports Fiscal First Quarter 2026 Financial Results and Provides Corporate Update
WOBURN, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced financial results for the fiscal first quarter …
vTv Therapeutics Announces First Study Participant Randomized in CATT1 Phase 3 Trial of Cadisegliatin in Type 1 Diabetes
HIGH POINT, N.C., Aug. 07, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company with an innovative clinical portfolio of small molecules and lead program in diabetes, today announced the first study …
RAPT Therapeutics Reports Second Quarter 2025 Financial Results
SOUTH SAN FRANCISCO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT” or the “Company”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel …
Humacyte to Present Second Quarter Financial Results and Provide Corporate Update on August 11, 2025
DURHAM, N.C., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, will release its financial results for the …
Geotab at 25: Driving the Future of Connected Vehicles
OAKVILLE, Ontario, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Today, Geotab marks its 25th anniversary, celebrating remarkable global growth, pioneering AI driven innovation, and a relentless focus on customers, partners, and employees. What began as a two-person …
Xunlei Limited Schedules 2025 Unaudited Second Quarter Earnings Release on August 14, 2025
SHENZHEN, China, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Xunlei Limited (“Xunlei” or the “Company”) (NASDAQ: XNET), a leading technology company providing distributed cloud services in China, today announced that it plans to release its unaudited financial …
Annovis Completes Full Patent Transfer to Crystal Buntanetap
Annovis achieves comprehensive intellectual property (IP) protection now covering both the original semi-crystalline and new crystalline forms of buntanetap. Both forms are covered by a total of 13 patent families. All patents are filed internationally, …
Genius Group executes buyback of one million shares as part of approved 20% share buyback mandate
SINGAPORE, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced that during the last three trading days, the Company bought back …